Hexagon Nutrition Ltd (HEXAGON)

📊 Quarterly Results (₹ Cr)

Revenue growth has accelerated sharply, with Q1 FY27 revenue up 43.2% YoY to ₹104.3 crores, outpacing earlier quarters where growth was more modest (e.g., ₹115 crores in Q3 FY26 and ₹100 crores in Q4 FY26). This growth is accelerating despite margin pressure, as EBITDA margin declined to 11.3% from 13.8% YoY due to strategic investments and raw material cost inflation in West Asia. The company is reinvesting gains into capacity and market expansion, particularly in branded and B2C segments, which management expects to drive higher-margin growth over time. Profitability remains healthy with PAT up 25.1% YoY, but the earnings trajectory reflects a deliberate trade-off between growth and margin discipline.

🔮 Management Outlook & What's Next

Management has outlined a target of 20-25% revenue growth for FY27, with branded products expected to account for 35% of total revenue. They attribute this growth to expansion into Tier 2/3 markets, e-commerce channels, and sustainable pricing power through MRP hikes. Management also emphasized confidence in long-term opportunities in the nutrition space, citing international expansion and innovation as key pillars. While no formal long-term guidance was provided beyond FY27, they stressed disciplined capital allocation and sustainable growth, aligning with post-IPO strategic priorities. The focus remains on scaling the business while managing cost pressures and integrating structural changes from recent amalgamations.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

The balance sheet remains relatively stable, with total assets growing from ₹183 crores in March 2022 to ₹318 crores in March 2026, driven by organic growth and investments. Borrowings have increased modestly from ₹24 crores to ₹33 crores over four years, indicating conservative leverage (D/E of 0.15), while equity and reserves have expanded significantly, reflecting retained earnings and capital base growth post-IPO. This suggests management is funding growth primarily through internal accruals and minimal debt, preserving financial flexibility. The strong equity base also cushions the company against short-term operational volatility, particularly in overseas subsidiaries where material uncertainties persist.

💰 Cash Flow Statement (₹ Cr)

👥 Shareholding Pattern

Promoter holding remains dominant at 64.29% in Q1 FY27, though slightly diluted from pre-IPO levels, with FII and DII participation growing to 0.29% and 6.43% respectively, indicating gradual institutional interest. The recent insider purchase by promoter group member Anuradha Kelkar, increasing her stake to 7.38%, signals continued confidence from the founding family. The number of shareholders has expanded from 82 to over 20,000, reflecting broader retail participation post-listing. There are no indications of significant promoter pledging or exit, and the shareholder base is becoming more diversified, though still concentrated among promoters.

⚖️ Peer Comparison — FMCG

🔗 Peer Stock Analyses

⚠️ Risk Factors

1) Material uncertainties in two overseas subsidiaries could impact future cash flows and operational stability, despite auditor confirmation of no material misstatements. 2) EBITDA margin compression due to raw material cost inflation in West Asia and growth investments may pressure near-term profitability. 3) High dependence on branded product adoption and execution of capacity expansion in Nashik poses execution risk. 4) Non-comparability of financials due to amalgamation may reduce transparency in trend analysis. These factors require monitoring, especially as the company scales its B2C footprint.

📋 Recent Filings

• 🔴 Announcement2026-09-29Hexagon Nutrition announced successful commercial-scale validation of PFH-VAP, a Vitamin A Palmitate formulation branded as VIT A+, intended for large…
• 🔴 Announcement2026-09-28Hexagon Nutrition Limited announced the cessation of Chairman and Executive Director Arun Kelkar effective September 28, 2026, marking the end of his …
• 🔴 Announcement2026-09-28Hexagon Nutrition announced the end of Mr. Arun Kelkar's term as Chairman and Executive Director effective September 28, 2026, concluding his tenure a…
• 🟡 Board Meeting2026-09-26Hexagon Nutrition announced a board meeting on September 30, 2026, to consider appointing Arun Kelkar as Executive Director and Chairman, approve remu…
• Announcement2026-09-25Hexagon Nutrition Limited announced that its trading window will close on October 1, 2026, for all insiders until 48 hours after the quarterly results…
• 🟡 corporate governance2026-09-23Hexagon Nutrition Limited disclosed that promoter shareholders abstained from voting on certain resolutions, prompting the company to seek an independ…
• 🟡 Board Meeting2026-09-23Hexagon Nutrition Limited announced amendments to its Memorandum and Articles of Association following shareholder approval at the 33rd Annual General…
• 🟡 Board Meeting2026-09-23Hexagon Nutrition announced that shareholders approved the appointment of N. L. Bhatia & Associates as secretarial auditors for five years starting Ap…
• 🔴 annual report2026-09-23Hexagon Nutrition Limited announced shareholder approval at its September 22, 2026 AGM for the re-appointment of Mr. Nikhil Kelkar as Joint Managing D…
• 🟡 Board Meeting2026-09-22Hexagon Nutrition held its 33rd AGM on 22 September 2026 via video conference, approving the 2025-26 financial statements, declaring a dividend, ratif…

🧠 Analyst's Read

Hexagon Nutrition is in a high-growth, investment phase with strong top-line momentum and improving profitability, supported by a healthy order book and promoter confidence. Investors should monitor the pace of branded product contribution, margin recovery, and resolution of overseas subsidiary risks. While the financial trajectory is positive, the company's future performance will depend on disciplined capital allocation and successful integration of its expansion strategy.

Based on filing content and financial data. Not a recommendation.